Drawing for CAREDEPLOY

USPTO serial 90638707

CAREDEPLOY

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
MCBRIDE, CAMERON L
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with CAREDEPLOY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

David G. Duckworth

David G. Duckworth ONE LLP4000 MACARTHUR BLVD.EAST TOWER, SUITE 500NEWPORT BEACH, CA 92660

Goods and services

ClassDescriptionStatusFirst use
035Healthcare management service organization (MSO) services, namely, providing practice organization, management and administrative support services to individual physicians or small group practices; Health care cost containment; Health care utilization and review services; Management of health care clinics for others; Consulting services in the cost management of health careACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
May 1, 2023MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
May 1, 2023ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Oct 1, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 29, 2022EX1GSOU EXTENSION 1 GRANTED—
Sep 29, 2022EXT1SOU EXTENSION 1 FILED—
Sep 29, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 29, 2022NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Feb 1, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 1, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 12, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 29, 2021PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Dec 29, 2021ALIEASSIGNED TO LIE—
Dec 27, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 9, 2021XAECEXAMINER'S AMENDMENT ENTERED—
Dec 9, 2021GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Dec 9, 2021GNEAEXAMINERS AMENDMENT E-MAILED—
Dec 9, 2021CNEAEXAMINERS AMENDMENT -WRITTEN—
Dec 2, 2021DOCKASSIGNED TO EXAMINER—
Jul 19, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 15, 2021NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance